Compound 525
Identifiers
- Canonical SMILES:
COc1cccc(c1)-c1nc2n(C)ncc2c2[nH]n(-c3cccc(F)c3)c(=O)c12
- InChi:
InChI=1S/C21H16FN5O2/c1-26-20-16(11-23-26)19-17(18(24-20)12-5-3-8-15(9-12)29-2)21(28)27(25-19)14-7-4-6-13(22)10-14/h3-11,25H,1-2H3
- InChiKey:
FRWCXXLFEUORIB-UHFFFAOYSA-N
External links
168318190 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD80 / CD28 | 7.09 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 389.13 g/mol | |||
HBA | 7 | |||
HBD | 1 | |||
HBA + HBD | 8 | |||
AlogP | 4.10 | |||
TPSA | 72.28 | |||
RB | 3 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4866 | ATX-914 | DB12673 | |
0.4812 | Riociguat | DB08931 | |
0.4798 | Merestinib | DB12381 | |
0.4715 | Vericiguat | DB15456 | |
0.4604 | 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE | DB07218 | |
0.4558 | AZD-5423 | DB12280 | |
0.4498 | MK-6186 | DB12999 | |
0.4468 | Tepotinib | DB15133 | |
0.4465 | MK-0249 | DB11910 | |
0.4440 | Neflamapimod | DB07138 | |
0.4426 | Dilmapimod | DB12140 | |
0.4409 | 5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | DB08534 | |
0.4390 | N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide | DB08349 | |
0.4363 | AMG-337 | DB15639 | |
0.4336 | (13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE | DB06888 |